Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00670293 · ClinicalTrials.gov registry record
Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa
A clinical trial, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 50
- Enrollment target
NCT00670293 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 50 participants.
The verdict
NCT00670293 has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study will use positron emission tomography imaging to investigate changes in dopamine systems in people with anorexia nervosa before and after weight restoration.
Interventions
- DRUG Methylphenidate
- PROCEDURE Magnetic Resonance Imaging (MRI) scan
- RADIATION Positron Emission Tomography (PET) using [11C]raclopride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-07 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00670293
The ClinicalTrials.gov registry entry for NCT00670293 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Methylphenidate is the first listed.
NCT00670293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00670293 about?
NCT00670293 is a clinical study titled "Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa". This study will use positron emission tomography imaging to investigate changes in dopamine systems in people with anorexia nervosa before and after weight restoration.
What is the current status of trial NCT00670293?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2008-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00670293?
The interventions under investigation include: Methylphenidate (DRUG), Magnetic Resonance Imaging (MRI) scan (PROCEDURE), Positron Emission Tomography (PET) using [11C]raclopride (RADIATION).
Who is sponsoring clinical trial NCT00670293?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.